Dear All:
The new Novo REPAIR impact fund ($165m over 5 years for antibacterials) is now open for applications — see the template at this link. Applications are due 15 May.
Relatedly, Novo would like to hire a Senior Associate to help manage the fund. Primary qualifications are (1) scientific understanding of microbiology or a related field (PhD preferred) and (2) at least one year’s investment experience in either venture investing or corporate business development. The position is based in Copenhagen. Inquiries should be made to Hanne Veitland (HVeitland@SpencerStuart.com).
While you’re considering these opportunities, don’t forget that…
- CARB-X will have another open application round during 1-8 June 2018
- CARB-X has job openings
- BARDA’s DRIVe initiative has job openings
is one of these for you? I hope so! All best wishes, –jr
John H. Rex, MD | Chief Medical Officer, F2G Ltd. | Expert-in-Residence, Wellcome Trust. Follow me on Twitter: @JohnRex_NewAbx. See past newsletters and subscribe for the future: http://amr.solutions/blog/
Upcoming meetings of interest to the AMR community:
- 16 Apr 2018 (Washington): Duke-Margolis & FDA event: “Evaluating Inclusion and Exclusion Criteria in Clinical Trials”
- 21-24 Apr 2018 (Madrid): ECCMID
- 4-7 Jun 2018 (Boston): BIO (multiple AMR-focused sessions are expected)
- 7-11 Jun 2018 (Atlanta): ASM Microbe
- 22-27 Jul 2018 (Bryant University, Smithfield, RI): Gordon Research Conference on Drug Resistance for Cancer, Infectious Disease and Agriculture
- 4-7 Sep 2018 ESCMID-ASM Conference (#3) on Drug Development for AMR (Lisbon, Portugal)
- 3-7 Oct 2018 (San Francisco): ID Week
- 6-14 Oct 2018 International Course on Antibiotics and Resistance(ICARe, Les Pensières, Annecy, France)
